The Limited Times

Now you can see non-English news...

New study in the fight against cancer: researchers encounter valuable findings

2020-12-28T16:59:16.307Z


Cancer is now a widespread disease and in many cases is fatal. Scientists have now come across a promising active ingredient.


Cancer is now a widespread disease and in many cases is fatal.

Scientists have now come across a promising active ingredient.

  • Cancer cells

    develop and multiply in the body in an uncontrolled manner.

  • The results of a

    study

    now report new

    findings

    in the fight against

    cancer

    *.

  • Researchers at

    the Max Planck Institute discovered an

    inhibiting agent

    that prevents cancer cells from growing.

Kassel -

Cancer diseases

are unfortunately not uncommon these days and are the second most common

cause of death

after cardiovascular diseases

.

But there are high hopes in cancer therapy: after intensive research, scientists are now providing information about a

new active ingredient

that inhibits the growth of cancer cells and is also well tolerated.

New findings in cancer study: researchers discover inhibiting agent

According to the Federal

Ministry of

Health,

cancer

is the malignant development of body cells which, in contrast to healthy body cells, multiply in an uncontrolled manner.

As the specialist portal heilpraxis.net now reports, researchers at the

Max Planck Institute for Biology of Aging have

now reached a

milestone in cancer research

: They discovered an active ingredient that

can prevent

the unrestrained

growth of cells

.

Scientists only recently discovered that bacteria can be used as cures for cancer.

According to a recent announcement from the

institute

, the newly developed active ingredient

“starves”

cancer cells

by attacking the mitochondria, which are important for spreading.

Mitochondria are cell organelles that supply cells with energy and building blocks, which in turn are necessary for the normal function of tissues and organs.

According to experts, cancer stem cells are heavily dependent on a mitochondrial metabolism in order to continue to multiply.

Study in the fight against cancer: Scientists develop new active ingredient

The scientists from the Max Planck Institute for Biology of Aging, the Stockholm Karolinska Institute and the University of Gothenburg report in the journal “Nature” that their

study could have

promising results

in

cancer therapy

in humans.

In contrast to drugs that have already been developed, which inhibit the function of the mitochondria but are toxic, the researchers have now developed an

active ingredient

that is particularly well tolerated.

"We have succeeded

in developing

a potential

cancer drug

that

targets

the function of the mitochondria without causing serious side effects and without damaging healthy cells," said study author Dr.

Nina Bonekamp from the Max Planck Institute for Biology of Aging.

+

Promising results from a cancer study: researchers discovered an active ingredient that can inhibit the growth of cancer cells.

(Symbol image)

© Arne Dedert / dpa

Latest cancer study: the active ingredient slows growth and is well tolerated

Mitochondria contain their own hereditary substance or a genetic material, the reading of which is controlled by special proteins.

One of these proteins is the enzyme "mitochondrial RNA polymerase", or POLRMT for short.

The researchers came in collaboration with the Lead Discovery Center

to the realization that a

POLRMT-inflammatory agent

, the

cancer cells

can die and the

tumor growth

may slow sharply.

The tests were carried out on mice with tumor diseases, which also tolerated the inhibiting agent very well.

“Our data suggests that we are basically starving cancer cells to death.

This works, at least for a while, without any major, toxic side effects.

This gives us a potential therapeutic window of time for

treating cancer,

”explains Dr.

Nina Bonekamp according to heilpraxis.net.

In addition, she is certain that the valuable test results and findings obtained will be used in many areas of

cancer therapy in the

future.

(Alina Schröder)

* hna.de is part of the nationwide Ippen-Digital editorial network.

List of rubric lists: © Arne Dedert / dpa

Source: merkur

All life articles on 2020-12-28

You may like

News/Politics 2024-02-01T11:21:36.889Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.